These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11376327)

  • 1. Immune control of HIV: the obstacles of HLA and viral diversity.
    Walker BD; Korber BT
    Nat Immunol; 2001 Jun; 2(6):473-5. PubMed ID: 11376327
    [No Abstract]   [Full Text] [Related]  

  • 2. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
    Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
    Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial antigens for HIV vaccine design.
    Expert Rev Vaccines; 2007 Jun; 6(3):301. PubMed ID: 17542744
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV T cell vaccines, the importance of clades.
    McMichael A; Mwau M; Hanke T
    Vaccine; 2002 May; 20(15):1918-21. PubMed ID: 11983245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity considerations in HIV-1 vaccine selection.
    Gaschen B; Taylor J; Yusim K; Foley B; Gao F; Lang D; Novitsky V; Haynes B; Hahn BH; Bhattacharya T; Korber B
    Science; 2002 Jun; 296(5577):2354-60. PubMed ID: 12089434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 8. Diversity and variation in human immunodeficiency virus: implications for immune control.
    Ramsay AJ
    Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():215-21. PubMed ID: 1452223
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cellular immunity in protection against HIV infection.
    Rowland-Jones S; Tan R; McMichael A
    Adv Immunol; 1997; 65():277-346. PubMed ID: 9238512
    [No Abstract]   [Full Text] [Related]  

  • 10. Advantage of rare HLA supertype in HIV disease progression.
    Trachtenberg E; Korber B; Sollars C; Kepler TB; Hraber PT; Hayes E; Funkhouser R; Fugate M; Theiler J; Hsu YS; Kunstman K; Wu S; Phair J; Erlich H; Wolinsky S
    Nat Med; 2003 Jul; 9(7):928-35. PubMed ID: 12819779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic complementarity between HIV and other AIDS-associated infections results in idiotype-antiidiotype antibody complexes that cross react with lymphocyte proteins.
    Root-Bernstein R
    Vaccine; 2005 Mar; 23(17-18):2160-3. PubMed ID: 15755587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity.
    Frahm N; Nickle DC; Linde CH; Cohen DE; Zuñiga R; Lucchetti A; Roach T; Walker BD; Allen TM; Korber BT; Mullins JI; Brander C
    AIDS; 2008 Feb; 22(4):447-56. PubMed ID: 18301057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
    Oxenius A; Price DA; Hersberger M; Schlaepfer E; Weber R; Weber M; Kundig TM; Böni J; Joller H; Phillips RE; Flepp M; Opravil M; Speck RF;
    J Infect Dis; 2004 Apr; 189(7):1199-208. PubMed ID: 15031788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and construction of a recombinant epitope-peptide gene as a universal epitope-vaccine strategy.
    Liu Z; Chen YH
    J Immunol Methods; 2004 Feb; 285(1):93-7. PubMed ID: 14871538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
    Sanchez-Merino V; Farrow MA; Brewster F; Somasundaran M; Luzuriaga K
    J Infect Dis; 2008 Jan; 197(2):300-8. PubMed ID: 18177249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-- tailored to fit.
    Dell H
    Drug Discov Today; 2004 Feb; 9(3):101. PubMed ID: 14968761
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV and human leukocyte antigen association--the Indian scenario.
    Shankarkumar U
    J HIV Ther; 2004 Sep; 9(3):60-4. PubMed ID: 15534563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.